About
Martin Zeidler is a Reader in Cell Signalling at the School of Biosciences, University of Sheffield. His research focuses on the JAK/STAT pathway in both Drosophila and human contexts, particularly its role in hematopoietic malignancies, inflammatory diseases, and myeloproliferative neoplasms. He leads a lab that employs RNAi screening and developmental genetics to uncover pathway regulators.
- BSc in Biology with European Studies (German), University of Sussex
- Pre-doctoral student at European Molecular Biology Laboratory (EMBL)
Research Interests:
- Elucidating JAK/STAT pathway regulators in Drosophila and human systems
- Linking pathway dysregulation to cancer and inflammatory disorders
- Developing zebrafish models for myeloproliferative neoplasms
- Drug repurposing strategies, including methotrexate as a JAK/STAT inhibitor
Scientific Awards:
- CR-UK Senior Cancer Research Fellow
- Emmy Noether Independent Group Leader
- Fellow of the Higher Education Academy (FHEA)
Collaborations: Tony Green (Cambridge), Stefan Constantinescu (Brussels), Iwan Evans (Drosophila hematopoiesis), Sally Thomas and John Snowden (NHS hematology).
0Publications listed
